C

Carolina BioOncology Institute | Huntersville, NC

Research site
(Unclaimed)
Location
9801 Kincey Avenue Suite 145, Huntersville, North Carolina, United States of America
Site insights

Top conditions

Cancer (1 trial)

Prostatic Cancer (1 trial)

Top treatments

Budigalimab
ABBV-181
ABBV-969
ABBV-303

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Adverse Events, How Intravenously (IV) Infused ABBV-303 Moves Through the Body, and Change in Disease State, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adult Participants With Advanced Solid Tumors

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess safety, tolera...

Enrolling
Solid Tumors
Drug: Budigalimab
Drug: ABBV-303

Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide. The purpose of thi...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: ABBV-969

Trial sponsors

AbbVie logo

AbbVie (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems